Copyright © 2012 Youssouf Radjab et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. Oparil, H. K. Berecek, A. D. Calhoun, and J. M. Wyss, “The role of the central nervous system,” in Hypertension, J. H. Laragh and B. M. Brenner, Eds., Raven Press, New York, 1995.
2. M. Pagani and D. Lucini, “Autonomic dysregulation in essential hypertension: insight from heart rate and arterial pressure variability,” Autonomic Neuroscience, vol. 90, no. 1-2, pp. 76–82, 2001. View at Publisher · View at Google Scholar · View at Scopus
3. H. Benjelloun, S. Aboudrar, I. Jroundi, H. Benjelloun-Bennani, L. Coghlan, and M. Benomar, “Sympathetic response in primary hypertension,” Annales de Cardiologie et d'Angeiologie, vol. 58, no. 3, pp. 139–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
4. G. Parati and M. Valentini, “Clinical relevance of blood pressure variablility,” in Journal of Hypertention, vol. 16, supplement 3, pp. S25–S33, 1998.
5. A. Rodgers, S. MacMahon, T. Yee, and T. Clark, “Blood pressure, cholesterol, and stroke in eastern Asia,” The Lancet, vol. 352, no. 9143, pp. 1801–1807, 1998. View at Scopus
6. P. Marques-Vidal and J. Tuomilehto, “Hypertension awareness, treatment and control in the community: is the “rule of halves” still valid?” Journal of Human Hypertension, vol. 11, no. 4, pp. 213–220, 1997. View at Scopus
7. C. J. L. Murray and A. D. Lopez, The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020, WHO, Geneva, Switzerland, 1996.
8. S. Julius, “Amlodipine in hypertension: an overview of the clinical dossier,” Journal of Cardiovascular Pharmacology, vol. 12, no. 7, pp. S27–S33, 1988. View at Scopus
9. S. S. Franklin, S. A. Khan, N. D. Wong, M. G. Larson, and D. Levy, “Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study,” Circulation, vol. 100, no. 4, pp. 354–360, 1999. View at Scopus
10. J. E. Muller, G. H. Tofler, and R. L. Verrier, “Sympathetic activity as the cause of the morning increase in cardiac events: a likely culprit, but the evidence remains circumstantial,” Circulation, vol. 91, no. 10, pp. 2508–2509, 1995. View at Scopus
11. D. J. Ewing, C. N. Martyn, R. J. Young, and B. F. Clarke, “The value of cardiovascular autonomic function tests: 10 years experience in diabetes,” Diabetes Care, vol. 8, no. 5, pp. 491–498, 1985. View at Scopus
12. D. J. Ewing, J. B. Irving, F. Kerr, J. A. Wildsmith, and B. F. Clarke, “Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function,” Clinical Science and Molecular Medicine, vol. 46, no. 3, pp. 295–306, 1974. View at Scopus
13. P. A. Low, “Laboratory evaluation of autonomic function,” in Clinical Autonomic Disorders. Evaluation and Managment, P. A. Low, Ed., pp. 179–208, Lippincott-Raven, Philadelphia, Pa, USA, 2nd edition, 1997.
14. H. C. Coghlan, “Orthostatic intolerance: mitral valve prolapse,” in Primer on the Autonomic Nervous System, D. Robertson, P. A. Low, and J. Polinsky, Eds., pp. 283–286, Academic Press, San Diego, Calif, USA, 1996.
15. T. L. Johansen, G. Kambskar, and J. Mehlsen, “Heart rate variability in evaluation of the autonomic nervous system,” Ugeskr Laeger, vol. 159, pp. 6666–6671, 1997.
16. P. F. J. Barjon, “Mimran A. Régulation de la pression artérielle,” in Physiologie Humaine, Ph. Meyer, Ed., Paris, France, 1977.
17. G. Serratrice, F. Billé-Turc, and J. Serratrice, Système Nerveux Autonome. Editions Techniques, EMC Neurologie, 1995.
18. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, “Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies,” The Lancet, vol. 360, no. 9349, pp. 1903–1913, 2002. View at Publisher · View at Google Scholar · View at Scopus
19. K. Miwa, A. Igawa, Y. Miyagi, K. Nakagawa, and H. Inoue, “Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment,” American Heart Journal, vol. 135, no. 5, pp. 762–771, 1998. View at Publisher · View at Google Scholar · View at Scopus
20. P. Balansard, J. N. Poggi, and A. Baralla, “Variabilité tensionnelle et morbidité,” Archives des Maladies du Coeur et des Vaisseaux, vol. 83, pp. 1089–1093, 1990.
21. D. S. Goldstein, C. Holmes, R. O. Cannon, G. Eisenhofer, and I. J. Kopin, “Sympathetic cardioneuropathy in dysautonomias,” The New England Journal of Medicine, vol. 336, no. 10, pp. 696–702, 1997. View at Publisher · View at Google Scholar · View at Scopus
22. M. P. Schlaich, H. Krum, P. A. Sobotka, and M. D. Esler, “Renal denervation and hypertension,” American Journal of Hypertension, vol. 24, no. 6, pp. 635–642, 2011. View at Publisher · View at Google Scholar · View at Scopus
23. B. Milovanović, D. Trifunović, N. Milićević, K. Vasić, and M. Krotin, “The significance of amlodipine on autonomic nervous system adjustment (ANSA Method): a new approach in the treatment of hypertension,” Srpski Arhiv Za Celokupno Lekarstvo, vol. 137, no. 7-8, pp. 371–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
24. K. Sakata, M. Shirotani, H. Yoshida et al., “Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension,” Hypertension, vol. 33, no. 6, pp. 1447–1452, 1999. View at Scopus
25. J. R. Sowers, “Hypertension in the elderly,” American Journal of Medicine, vol. 82, no. 1, pp. 1–8, 1987. View at Scopus
26. I. V. Ilias Zarkos, “Eleftherios thireos, gerasimos livieratos, aikaterini mitropoulou, nearchos nearchou and vasilis tolis sympathovagal balance in essential hypertensives treated with angiotensin receptor blockers for a long period of time,” American Journal of Hypertension, vol. 254, 2004, abstract no. P-254: 17, 125A.
27. M. A. Kosch, M. Hausberg, M. Barenbrock, K. Kisters, and K. H. Rahn, “Studies on cardiac sympathovagal balance and large artery distensibility in patients with untreated essential hypertension,” Journal of Human Hypertension, vol. 13, no. 5, pp. 315–319, 1999. View at Scopus
28. B. Milovanović, D. Trifunović, N. Milićević, K. Vasić, and M. Krotin, “The significance of amlodipine on autonomic nervous system adjustment (ANSA Method): a new approach in the treatment of hypertension,” Srpski Arhiv Za Celokupno Lekarstvo, vol. 137, no. 7-8, pp. 371–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
29. J. Minami, T. Ishimitsu, Y. Kawano, and H. Matsuoka, “Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients,” Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 7-8, pp. 572–576, 1998. View at Scopus
30. G. K. Pal, C. Adithan, D. Amudharaj et al., “Assessment of sympathovagal imbalance by spectral analysis of heart rate variability in prehypertensive and hypertensive patients in indian population,” Clinical and Experimental Hypertension, vol. 33, no. 7, pp. 478–483, 2011. View at Publisher · View at Google Scholar · View at Scopus
31. G. K. Pal, P. Pal, N. Nanda, V. Lalitha, T. K. Dutta, and C. Adithan, “Sympathovagal imbalance in prehypertensive offspring of two parents versus one parent hypertensive,” International Journal of Hypertension, vol. 2011, Article ID 263170, 8 pages, 2011. View at Publisher · View at Google Scholar
32. M. Weck, “Treatment of hypertension in patients with diabetes mellitus: relevance of sympathovagal balance and renal function,” Clinical Research in Cardiology, vol. 96, no. 10, pp. 707–718, 2007. View at Publisher · View at Google Scholar · View at Scopus